The ROTEM platelet system is a new module that can be added to the ROTEM, enabling simultaneous analysis of thromboelastometry measurements and platelet aggregation using impedance aggregometry.

###### 

Platelet aggregometry using ROTEM
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**ROTEM platelet aggregation graph**

In ROTEM PM, effect of various antiplatelet drugs can be studied through single use agent; **ARA-TEM** for cyclooxygenase inhibitors, **ADP-TEM** for ADP receptor blocker and **TRAP-TEM** for glycoprotein IIbIIIa receptor blockers.

**ROTEM platelet mapping system**

ROTEM PM system^3^ is a new module that can be added to ROTEM, enabling simultaneous analysis of thromboelastometry & platelet aggregation using impedance aggregometry (Figure Below).
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ROTEM monitor showing simultaneous graphs of thromboelastometry (upper 4) and platelet aggregometry (lower 2)

**RAPID ASSESSMENT IN ONLY 10 MINUTES**
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**IMPEDANCE AGGREGOMETRY: ACTIVATOR PATHWAYS**
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**ROTEM PLATELET ACTIVATORS AND PARAMETERS**

Platelet aggregometry tests

1.[Aratem]{.ul} -- Arachidonic acid2.[Traptem]{.ul} -- Thrombin activating Peptide3.[Adptem]{.ul} -- Adenosine Diphosphate

Platelet Parameters

1.Amplitude at 6 Min.-A6 -- It describes how well the platelets aggregate after selective activation.2.Maximum Slope. MS -- It describes how quick the platelets aggregate after selective activation.3.Area Under the Curve-AUC- It reflects the overall platelet aggregation.
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**Conclusion:**

Major bleeding is a partially modifiable risk factor, and adequate preemptive and treatment strategies should be applied to limit this event. ROTEM PLATELET AGGREGOMETRY provides great blood product usage and is cost effective when used in time.
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